Diagnostic Biochips, Inc.
Glen Burnie, MD
- UEI
- PF2EA6V5G9E3
- CAGE
- 6W3E6
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 801 Cromwell Park Dr #103, Glen Burnie, MD 21061, USA
- Website
- diagnosticbiochips.com
- Founded
- 2012
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 38 Instruments & Related Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $1,098,051 |
| FY2025 | $0 |
| FY2024 | $20,000 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Health and Human Services | $1,098,051 |
Contract awards
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Plexon, Inc. | Dallas, TX | 541990 All Other Professional, Scientific, and Technical Services |
| Nuvectra | Ann Arbor, MI | 334519 Other Measuring and Controlling Device Manufacturing |
| Maxwell Biosystems AG | Zürich, ZH | 334516 Analytical Laboratory Instrument Manufacturing |
| Axion Biosystems, Inc. | Atlanta, GA | 334516 Analytical Laboratory Instrument Manufacturing |
| Biopac Systems, Inc. | Goleta, CA | 334510 Electromedical and Electrotherapeutic Apparatus Manufacturing |
About the company
Diagnostic Biochips, Inc., a Glen Burnie, Maryland–based manufacturer of electrophysiology recording equipment, operates as a prime contractor delivering specialized diagnostic and research instrumentation to federal health and defense agencies on full-and-open contract awards, with no subcontract footprint.
The company's core capability is the design and manufacture of high-throughput multi-electrode array (MEA) systems for in vitro electrophysiology research, particularly the SomaFocus 3D platform, which records electrophysiological signals from human iPSC-derived brain organoids with penetration depths to 200 micrometers and minimum sampling rates of 10 kHz per electrode. The most recent work includes a $918,951 firm-fixed-price definitive contract awarded by the Food and Drug Administration in September 2026 for a high-throughput physiology tool supporting NAMS-based (next-generation alternatives to animal models) safety studies, running through September 2029. In the same month, FDA awarded a $275,100 purchase order under a Total Small Business set-aside for a SomaFocus 3D MEA system with factory-certified installation, operator training, platinum service warranty, application software with cloud backup, and consumables including 60 custom microwell plates and 60 organoid probes. A third recent award was a $20,000 purchase order from the National Institute of Neurological Disorders and Stroke in September 2024 for investigational use of diagnostic biochips deep array probes.
Customer concentration splits between research and development agencies. The Department of Health and Human Services National Institutes of Health accounts for five awards; the Food and Drug Administration holds two awards totaling $1.2 million in combined potential value; and the Defense Advanced Research Projects Agency anchors one award valued at $1.9 million. Ten total awards span a thirteen-year window (first award May 2013, most recent September 2026), with combined potential value of $3.1 million against obligated dollars of $5.6 million — a signal of contract modifications and task extensions beyond original ceiling. The vendor does not compete under SBA set-asides; recent awards use either full-and-open or Total Small Business designations. Diagnostic Biochips operates exclusively as a prime and maintains no subcontractor relationships in the federal footprint.
Quick answers
Is Diagnostic Biochips, Inc. registered in SAM.gov?
Yes. Diagnostic Biochips, Inc.'s SAM.gov registration is active through March 2, 2027.
How much has Diagnostic Biochips, Inc. received in federal contracts?
Federal contracts obligated $1,118,051 to Diagnostic Biochips, Inc. in fiscal years 2023 through 2027.
What is Diagnostic Biochips, Inc.'s most recent federal award?
Diagnostic Biochips, Inc.'s most recent federal contract award is A high-throughput physiology tool for nams-based safety studies (75F40126C00208), from Food and Drug Administration, on September 30, 2026.
On GovTribe
See Diagnostic Biochips, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors